Key result
MECKI score predicts ~70% higher risk of CV death or urgent transplant in older HF patients.
Why the study?
Does the MECKI score maintain its prognostic value for cardiovascular death and urgent heart transplantation in older patients with chronic systolic heart failure?
Observational (n=3,794)
Yes
Does the MECKI score maintain its prognostic value for cardiovascular death and urgent heart transplantation in older patients with chronic systolic heart failure?
Effect estimate: HR 1.699 (95% CI 1.518-1.901)
p-value: p=<0.0001
The MECKI score is a valid prognostic tool for predicting cardiovascular death and urgent heart transplantation in both older (≥70 years) and younger patients with chronic systolic heart failure.
MECKI score may support risk stratification in older HF patients; extends validation to elderly cohort but leaves open need for prospective confirmation.
BACKGROUND: In patients with chronic heart failure (HF) the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score, is a predictor of cardiovascular death and urgent heart transplantation. We investigated the relationship between age, exercise tolerance and the prognostic value of the MECKI score. METHODS AND RESULTS: We analyzed data from 3,794 patients with chronic systolic HF. The primary endpoint was a composite of cardiovascular death and urgent heart transplantation. Older patients had higher prevalence of comorbidities and lower exercise performance compared with younger subjects (peak V̇O2, 925 vs. 1,351 L/min; P<0.0001; V̇E/V̇CO2slope, 33.2 vs. 28.3; P>0.0001). The rate of the primary endpoint was 19% in the highest age quartile and 14% in the lowest quartile. At multivariable analysis, the independent predictors of the primary endpoint were left ventricular ejection fraction (LVEF), eGFR, peak V̇O2, serum Na(+)and the use of β-blockers in patients aged ≥70 years, and LVEF, eGFR and peak V̇O2in younger subjects. The MECKI risk score increased across age subgroups, but on receiver operating characteristic curve analysis its prognostic power was similar in both patients aged ≥70 and <70 years. CONCLUSIONS: Older patients with HF are a high-risk population with lower exercise performance. The MECKI score increased according to age and maintained its prognostic value also in older patients.
No takes yet. Share an insight, caveat, or question.
Carubelli et al. (2015) conducted an observational in Chronic systolic heart failure (n=3,794). MECKI score (patients ≥70 years) was evaluated on Composite of cardiovascular death and urgent heart transplantation (HR 1.699, 95% CI 1.518-1.901, p=<0.0001). The MECKI score maintained its prognostic value for predicting cardiovascular death and urgent heart transplantation in older patients (≥70 years) with chronic heart failure (HR 1.699).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: